Recently, many studies have highlighted the effectiveness of prostate-specific membrane antigen (PSMA)-based positron emission tomography (PSMA-PET) for detecting oligo-metastatic prostate cancers. The gene discussed is FOLH1; the disease is metastatic prostate carcinoma.